Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life
Abstract Indomethacin is used commonly in preterm neonates for the prevention of intracranial hemorrhage and closure of an abnormally open cardiac vessel. Due to biomedical advances, the infants who receive this drug in the neonatal intensive care unit setting have become younger, smaller, and less...
Main Authors: | Wojciech Krzyzanski, Bradley Stockard, Andrea Gaedigk, Allison Scott, Whitney Nolte, Kim Gibson, J. Steven Leeder, Tamorah Lewis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12881 |
Similar Items
-
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
by: Bradley Stockard, et al.
Published: (2022-06-01) -
Efficacy of indomethacin compared with magnesium sulfate in the management of preterm labor in pregnancies less than 32 weeks
by: Jehad Ayoub, et al.
Published: (2018-09-01) -
Efficacy of indomethacin compared with magnesium sulfate in the management of preterm labor in pregnancies less than 32 weeks
by: Jehad Ayoub, et al.
Published: (2018-09-01) -
Comparison of Mg-Sulfate and Indomethacin in management of women with preterm labor
by: M.Asgharnia (M.D), et al.
Published: (2002-09-01) -
Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants
by: Olga I. Butranova, et al.
Published: (2023-03-01)